Healthcare Industry News: Becton, Dickinson
News Release - February 7, 2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
FRANKLIN LAKES, N.J., Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Development. Mr. Bhalla will join BD in March, 2014 and will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President.Mr. Bhalla, 39, will partner with the senior management team in driving the overall development of BD's strategy. The business development and corporate strategy functions will report to him.
He joins BD from Citi, where he served as Director – Equity Research – Life Science Tools/Medical Technology since 2006. Prior to that role, Mr. Bhalla served as Vice President – Equity Research – Emerging Medical Technology at Morgan Stanley, as well as Technical Operations/Research & Development Associate at Johnson & Johnson.
Mr. Bhalla earned his MBA from Carnegie Mellon University at the Tepper School of Business and holds a B.S. in biology from Cornell University.
About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.
Source: Becton, Dickinson
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
